JBC PeproTech; Our Business is Cytokines!

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liang, Y.
Right arrow Articles by Ackerman, S. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liang, Y.
Right arrow Articles by Ackerman, S. H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Volume 271, Number 43, Issue of October 25, 1996 pp. 26522-26528
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

Characterization of Mutations in the beta  Subunit of the Mitochondrial F1-ATPase That Produce Defects in Enzyme Catalysis and Assembly*

(Received for publication, July 9, 1996)

Yueling Liang and Sharon H. Ackerman Dagger

From the Department of Surgery and Department of Biochemistry and Molecular Biology, Wayne State University School of Medicine, Detroit, Michigan 48201

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
Acknowledgments
REFERENCES


ABSTRACT

The ATP2 gene, coding for the beta  subunit of the mitochondrial F1-ATPase, was cloned from nine independent isolates of chemically mutagenized yeast. Seven different mutant alleles were identified. In one case the mutation occurs in the mitochondrial targeting sequence (M1I). The remaining six mutations map to the mature part of the beta  subunit protein and alter amino acids that are conserved in the bovine heart mitochondrial and Escherichia coli beta  subunit proteins. Biochemical analysis of the yeast atp2 mutants identified two different phenotypes. The G133D, P179L, and G227D mutations correlate with an assembly-defective phenotype that is characterized by the accumulation of the F1 alpha  and beta  subunits in large protein aggregates. Strains harboring the A192V, E222K, or R293K mutations assemble an F1 of normal size that is none-the-less catalytically inactive. The effect of the atp2 mutations was also analyzed in diploids formed by crossing the mutants to wild type yeast. Hybrid enzymes formed with beta  subunits containing either the G133D, E222K, or R293K mutations are compromised for steady-state ATPase activity. The display of partial dominance confirms the importance of Gly133 for structural stability and of Glu222 and Arg293 for catalytic cooperativity.


INTRODUCTION

The F1-F0 ATP synthase (ATPase) of mitochondrial, chloroplast, and bacterial membranes catalyzes ATP synthesis coupled to respiration (1, 2). The enzyme is composed of a catalytic moiety, F1, attached peripherally to an integral membrane component, F0. Three types of subunits (designated a, b, and c in bacteria (3, 4)) constitute an evolutionarily conserved core F0 structure, and there is variation among species as to whether or not additional F0 subunits are present (5). F1 shows a remarkable degree of structural conservation, and in most organisms studied, exists as an oligomer of five different subunits with the stoichiometry alpha 3beta 3gamma delta epsilon (1, 2).

The x-ray structure of bovine mitochondrial F1 shows the alpha  and beta  subunits alternating in a hexagonal ring, with the amino and carboxyl termini of the gamma  subunit located in the central core of the ring (6). Six adenine nucleotide binding sites are located at the alpha /beta interfaces. Three of these sites are catalytic and reside primarily in the beta  subunit; the other three sites are noncatalytic and are contributed mostly by residues of the alpha  subunits (6). The three catalytic sites interact cooperatively during enzyme turnover; this process is probably mediated by conformational changes in the F1 subunits (1, 2). A principal focus in F1 research is to understand the mechanistic details that underlie catalytic cooperativity. The study of mutants with defects in the F1 subunits offers a means to test the catalytic function of amino acids and to identify the residues that propagate conformational changes in the enzyme. Several excellent reviews are available that document studies performed with Escherichia coli mutants to probe the structure/function relationships in F1 (7, 8, 9). The mitochondrial enzyme from Saccharomyces cerevisiae is equally amenable to genetic manipulation. Moreover, the analysis of yeast F1 mutants is of particular value now that an atomic structure of the mitochondrial enzyme is available (6).

Genetic studies with yeast F1 have centered on the beta  subunit, which is coded for by the ATP2 gene (10) in chromosome X (11). The work reported to date has used site-directed mutagenesis to effect changes in amino acids that were previously shown to react with chemical labels (12, 13) and also to change residues that constitute a sequence element conserved in several nucleotide binding proteins (the P-loop) (13, 14, 15). The present study constitutes the first report in which mutations induced chemically in the yeast beta  subunit gene were characterized both biochemically and genetically. Two classes of beta  subunit mutations were identified: those that alter catalysis without affecting the enzyme structure and those that produce defects in F1 assembly.


EXPERIMENTAL PROCEDURES

Yeast Strains and Growth Media

The genotypes and sources of the mutant and wild type yeast strains used in the present study are listed in Table I. Chemically induced mutants were obtained as described (17). E. coli RR1 (proA leuB lacY galK xyl-5 mtl-1 ara-14 rpsL supE hsdS lambda -) was the host bacterial strain for the recombinant plasmid constructions. Yeast was grown in the following media: YPD (2% glucose, 2% peptone, 1% yeast extract), YPGal (2% galactose, 2% peptone, 1% yeast extract), YEPG (3% glycerol, 2% ethanol, 2% peptone, 1% yeast extract), WO (2% glucose, 0.67% yeast nitrogen base without amino acids (Difco)). Amino acids and other growth requirements were added at a final concentration of 20 µg/ml. The solid media included 2% agar.

Table I.

Genotypes and sources of S. cerevisiae strains


Strain Genotype Sources

D273-10B/A1  alpha met6 Ref. 16
W303-1A aade2-1 his3-1,15 leu2-3,112 ura3-1 trp1-1 a
W303-1B  alpha ade2-1 his3-1,15 leu2-3,112 ura3-1 trp1-1 a
C103  alpha met6 atp2-1 Ref. 17
E210  alpha met6 atp2-1 This study
E144  alpha met6 atp2-2 This study
E430  alpha met6 atp2-2 This study
E700  alpha met6 atp2-3 This study
E588  alpha met6 atp2-4 This study
P159  alpha met6 atp2-5 This study
P133  alpha met6 atp2-6 This study
N123  alpha met6 atp2-7 This study
aW303nabla G1 aade2-1 his3-1,15 leu2-3,112 ura3-1 trp1-1 atp2::LEU2 This study
 alpha W303nabla G1  alpha ade2-1 his3-1,15 leu2-3,112 ura3-1 trp1-1 atp2::LEU2 This study

a  R. Rothstein, Department of Human Genetics, Columbia University.

Preparation of Yeast Mitochondria

Yeast were grown aerobically in liquid YPGal at 30 °C to early stationary phase. The method of Faye et al. (18) was used to prepare mitochondria with the exception that zymolyase, instead of Glusulase, was used to digest the cell wall. Phenylmethylsulfonyl fluoride was added to 10 µg/ml final concentration during the cell-breaking step to minimize proteolysis.

Extraction of F1-F0 Proteins from Mitochondria

Mitochondria were suspended at 6.6 mg/ml in 10 mM Tris-HCl, pH 8.0, 2 mM EDTA, 4 mM ATP (TEA buffer) and incubated for 15 min with 0.25% Triton X-100 to extract the F1-F0 complex. The suspensions were centrifuged at 50,000 rpm in a Beckman 70.1Ti rotor for 30 min, and the resultant soluble and particulate fractions were assayed for F1 proteins by Western analysis.

Sucrose Gradient Centrifugation Analysis of F1-ATPase Subunits

Step sucrose gradients were used to analyze the properties of F1 subunits in cases where the enzyme was found to be resistant to Triton X-100 extraction. Mitochondria (5 mg/ml) were permeabilized in TEA buffer by a brief exposure to sonic irradiation, and 0.2-ml samples were overlaid on a 4.8-ml discontinuous gradient of Tris-HCl, pH 7.5, buffered sucrose (20-80%, w/v). The preparation of the step gradients and the centrifugation protocol were as described (19). Linear sucrose gradients were used to evaluate the size of the F1-F0 complex in mitochondrial supernatants following Triton X-100 extraction. Solubilized protein (0.6 ml) was loaded onto a 4.4-ml 6-20% sucrose gradient prepared in 0.1% Triton X-100-supplemented TEA buffer, and the gradients were centrifuged at room temperature for 1.5 h at 55,000 rpm in a Beckman SW55Ti rotor. For all experiments, sucrose gradient fractions were collected from the bottom of the tube.

Colony Hybridization

The mutant atp2 genes were cloned by the method of colony hybridization (20). Following digestion of yeast genomic DNA with SphI, 7-kilobase fragments were purified from a 1% agarose gel and subcloned into a SphI-cut yeast/E. coli shuttle plasmid (either pRS316, CEN (21) or YEp352, 2 µ (22)). The mini-SphI libraries were used to transform E. coli, and the colonies were hybridized at 65 °C with a nick-translated DNA fragment containing the entire ATP2 gene.

Construction of atp2 Null Strains

The one-step gene replacement method (23) was used to disrupt the chromosomal copy of ATP2 in the respiratory competent haploid yeasts W303-1A and W303-1B. The disruption allele (atp2::LEU2) was constructed by inserting a 2.8-kilobase BglII DNA fragment, carrying the entire LEU2 gene, into the unique BamHI site of the ATP2 reading frame. Wild type W303 strains were transformed with atp2::LEU2 on a linear DNA fragment and the transformants were screened for the stable acquisition of leucine prototrophy that correlated with the loss of respiratory function. Respiratory-deficient, Leu+ integrants of both mating types were obtained. Genetic crosses to rho o tester strains indicated that the respiratory defect of the disruption strains (W303nabla G1) was due solely to a nuclear mutation and Southern analysis verified that the gene disruption occurred at the ATP2 locus (data not shown). Genetic crosses also showed allelism between the disrupted gene in the W303nabla G1 strains and atp2 present in the chemically mutagenized yeast strains.

Assays

Protein concentrations were estimated by the method of Lowry et al. (24). ATPase activity was measured by determining the amount of inorganic phosphate released as described previously (25), in the absence and presence of 10 µg of oligomycin.

Miscellaneous Procedures

Restriction endonuclease digestion of DNA, purification and ligation of DNA fragments, E. coli transformation and preparation of bacterial plasmids, and nick translation followed standard protocols (26). The dideoxy method (27) was used to sequence the mutant atp2 genes; both strands of the gene were sequenced using overlapping oligonucleotide primers spaced ~180-200 nucleotides apart. Yeast transformations were done with the LiAc procedure (28). For Western analysis, proteins were separated on 12% polyacrylamide gels run in the electrophoretic system of Laemmli (29), modified as described (25) to optimize resolution of the F1 alpha  and beta  subunit proteins. The procedure of Schmidt et al. (30) was used for Western blotting. Antibodies against F1 alpha , F1 beta , and cytochrome c1 were used at dilutions of 1:2000, 1:3000, and 1:100 respectively.


RESULTS

Genetic Analysis of Yeast atp2 Mutants

Chemically mutagenized yeast strains belonging to complementation group G1 (17) carry mutations in ATP2, the nuclear gene that codes for the beta  subunit of the F1-F0 ATP synthase. The mutant atp2 genes were cloned from nine G1 strains, and the mutations were sequenced (see ``Experimental Procedures''). The position of these mutations in the nucleotide and protein sequences is shown in Table II. A single missense mutation was found in each of the mutants, which alters the sequence of ATP2 relative to the wild type copy present in the parental strain D273-10B/A1 (GenBankTM accession number U46215[GenBank]). Two of the mutations were found in more than one strain: the P179L substitution occurs in the strains C103 and E210, and the mutation E222K is present in the strains E430 and E144.1 The mutation in strain E700 converts the initiator methionine to isoleucine. Since this mutation does not provide information on residues involved in F1 biogenesis or catalysis, it will not be discussed further.

Table II.

Description of atp2 mutations

Nucleotide sequence numbering is according to D273-10B/A1 wild type ATP2 gene (GenBankTM accession number U46215[GenBank]) where the +1 nucleotide is the A of the ATG initiating codon. Amino acid numbering starts from the ATG initiator.
atp2 mutant Nucleotide Codon change Amino acid change

E700 3 ATG right-arrow ATA M1I
P133 398 GGT right-arrow GAT G133D
E210 536 CCT right-arrow CTT P179L
C103 536 CCT right-arrow CTT P179L
P159 575 GCA right-arrow GTA A192V
E430 664 GAA right-arrow AAA E222K
E144 664 GAA right-arrow AAA E222K
N123 680 GGT right-arrow GAT G227D
E588 878 AGA right-arrow AAA R293K

Mitochondrial ATPase Activity and F1-F0 Assembly in Haploid atp2 Mutant Strains

The amount of oligomycin-sensitive mitochondrial ATPase activity present in the mutant haploid strains is shown in Table III. All of the mutations produce a near complete loss (>= 93%) of ATPase activity. Western blots (Fig. 1) were used to determine the amount of F1 beta  subunit in each of the atp2 mutants; these values are also reported in Table III. The level of F1 beta  subunit protein ranges from 44 to 85% the control level and thus does not account for the reduction in mitochondrial ATPase activity observed in the mutant strains.

Table III.

ATPase activity of haploid yeast atp2 mutants


Strain (mutation) Amount beta  subunita Mitochondrial ATPase activity
 -Oligomycinb +Oligomycinb Oligomycin-sensitive activity

% control level µmol Pi/min/mg µmol Pi/min/mgc % control level
D273 100 4.30 (4.10) 0.34 (0.46) 3.80 100
P159 (A192V) 67 0.08 (0.20) 0.04 (0.14) 0.05 1.3
E430 (E222K) 85 0.13 (0.12) 0.08 (0.04) 0.06 1.6
E588 (R293K) 61 0.15 (0.12) 0.03 (0.05) 0.09 2.4
P133 (G133D) 49 0.16 (0.17) 0.08 (0.06) 0.09 2.4
E210 (P179L) 51 0.24 (0.22) 0.10 (0.15) 0.10 2.6
N123 (G227D) 44 0.14 (0.15) 0.04 (0.03) 0.11 2.9

a  The amount of F1 beta  subunit protein was determined using an AMBIS 4000 imaging system to scan Western blots of total mitochondrial protein. The mean values from the analysis of two separate Western blots are reported; one of the blots used is shown in Fig. 1.
b  Results from the assay of two separate mitochondrial preparations are shown; one set of values is given in parentheses.
c  The mean values are reported.


Fig. 1. Western analysis showing level of F1 alpha  and beta  protein in total mitochondrial protein. Mitochondrial samples (20 µg), prepared from the yeast strains shown, were loaded onto a 12% SDS-polyacrylamide gel. Following transfer to nitrocellulose, the blot was exposed to antibodies against the F1 alpha  and beta  subunits as described under ``Experimental Procedures.'' The position of the alpha  and beta  subunit bands are indicated in the left-hand margin.
[View Larger Version of this Image (35K GIF file)]


The effect of the mutations on the assembly of F1-F0 was also studied. The manner in which the F1 alpha  and beta  subunits distribute between soluble and particulate fractions when wild type and mutant mitochondria are extracted with 0.25% Triton X-100 is shown in the Western blots of Fig. 2. In the wild type (D273) the alpha  and beta  subunits distribute almost equally between the two fractions, indicating that this procedure solubilizes approximately 40-50% of the F1-F0 from the inner mitochondrial membrane. The strains P159, E430, and E588 show evidence for mutant beta  subunits with solubility properties that are comparable to those of the wild type protein. These strains were studied further to determine if the mutant protein is assembled into an F1-F0 complex of the correct size. Soluble Triton X-100 extracts of mitochondria prepared from D273, and from the strains P159, E430, and E588, were centrifuged through linear sucrose gradients and the position of the F1 alpha  and beta  subunit proteins was determined by Western analysis (Fig. 3). The F1 proteins in the mutant and the wild type samples showed comparable sedimentation properties. This result suggests that the A192V, E222K, and R293K mutations do not interfere with the formation of the F1-F0 structure.


Fig. 2. Western analysis showing F1-F0 extraction from mitochondria. Mitochondrial samples, prepared from the yeast strains shown, were extracted with 0.25% Triton X-100 and centrifuged as described under ``Experimental Procedures.'' Aliquots of total mitochondrial protein (M) and equivalent volumes of the particulate (P) and soluble (S) fractions were analyzed by Western as described in the legend to Fig. 1. The amount of mitochondrial protein loaded was 20 µg for D273 (wild type (WT)) and 30 µg for the mutants E210, P159, E430, and E588. The type of atp2 mutation is given in parenthesis under the name of the mutant strain. The position of the alpha  and beta  subunit bands are indicated in the left-hand margin.
[View Larger Version of this Image (21K GIF file)]



Fig. 3. Western analysis of linear sucrose gradient fractions. Mitochondria, prepared from the yeast strains shown, were extracted with 0.25% Triton X-100, and aliquots of the soluble fractions were centrifuged through 6-20% linear sucrose gradients as described under ``Experimental Procedures.'' Twenty fractions of equivalent volume were collected from the bottom of the tube, and 15 µl of each fraction were analyzed to detect the F1 alpha  and beta  subunits by Western analysis as described in the legend to Fig. 1. The position of the alpha  and beta  subunit bands are indicated in the left-hand margin.
[View Larger Version of this Image (29K GIF file)]


In the mutant strains E210 (P179L mutation), P133 (G133D mutation), and D123 (G227D mutation) virtually all of the beta  subunit, and most of the alpha  subunit, sediment in the particulate fraction after Triton solubilization of the mitochondrial membrane (data shown for strain E210 in Fig. 2). This pattern of extraction is indicative of a defect in F1-F0 assembly (19). The nature of this defect was investigated further by centrifuging permeabilized mitochondria through 20-80% step-sucrose gradients (see ``Experimental Procedures'') to determine if the insoluble F1 alpha  and beta  protein is membrane-bound or in an aggregated form (19). Fractions from the gradient were analyzed on Western blots for the F1 alpha  and beta  subunits and for cytochrome c1. The latter protein remains membrane-bound under the conditions used to permeabilize the mitochondria and serves to mark the position of the inner membrane in the gradient. Fig. 4 shows the results of this experiment for the wild type strain, D273, and for one of the atp2 mutants (E210) that harbors insoluble F1 protein. In the wild type (D273) the F1 alpha  and beta  subunits co-sediment with cytochrome c1 (peak at fraction 6), indicating that most of the F1 remains bound to F0 in the inner membrane under the conditions of the experiment (see also Ref. 19). In the mutant strain E210 the F1 subunits migrate separately from cytochrome c1 and peak in the region of high sucrose density (fractions 2 and 3). Results similar to those shown for E210 were obtained with mitochondrial samples from mutant strains P133 and N123 (data not shown). This analysis indicates that the beta  subunit mutations P179L, G133D, and G227D produce a defect in the assembly of F1 characterized by the intramitochondrial accumulation of alpha  and beta  subunit in large aggregates (see also Ref. 19).


Fig. 4. Western analysis of step sucrose gradient fractions. Mitochondria prepared from the wild type strain, D273, and from the mutant, E210, were permeabilized by sonic irradiation and centrifuged through 20-80% step sucrose gradients as described under ``Experimental Procedures.'' Ten fractions of equivalent volume were collected from the bottom of the tube, and 15 µl of each fraction were run on a 12% SDS-polyacrylamide gel. Following transfer to nitrocellulose, the blot was exposed to antibodies against the F1 alpha  and beta  subunits and cytochrome c1 (cytc1). The positions of the alpha , beta , and cytochrome c1 protein bands are indicated in the left-hand margin.
[View Larger Version of this Image (36K GIF file)]


Demonstration of Partial Dominance for the atp2 Point Mutations

The haploid yeast of the complementation group G1 are complemented in crosses to the wild type, which indicates the strains have recessive mutations in the ATP2 gene. However, in view of the catalytic and structural properties of the F1 enzyme, it may be argued that certain mutations in ATP2 should be partially dominant with respect to a wild type copy of the beta  subunit gene present in the same cell. There are three beta  subunits in F1 that are catalytic and the three catalytic sites interact cooperatively during enzyme turnover (1, 2). Studies using chemical (31) and photoaffinity (32) labels have shown that inactivating one of the three beta  subunits attenuates multisite catalysis in F1. Analysis of hybrid forms of E. coli F1, reconstituted in vitro from mixtures of mutant and wild type subunits (either alpha  (33) or beta  (34)), also show that inactivating a single catalytic site severely impairs F1 steady-state catalysis. These studies support the notion that the co-synthesis of mutant and wild type beta  subunits can lead to the formation of hybrid enzymes in vivo in which the cooperative interactions are lost. Alternatively, the presence of a mutant beta  subunit could exert a partially dominant effect by interfering with the assembly of a stable F1 structure.

To investigate if the atp2 mutations we identified are partially dominant over wild type ATP2, catalytic activity of the F1-F0 complex was analyzed in diploid strains formed by crossing the atp2 mutants to the wild type yeast, W303-1A. The level of oligomycin-sensitive ATPase was first measured in mitochondrial samples prepared from each of the strains (Table IV). The mitochondria were then extracted with 0.25% Triton X-100, and the amount of solubilized F1-F0 was quantified from Western blots (Fig. 5, Table IV). Finally, the specific activity of the F1-F0 complex was calculated by dividing the percent mitochondrial ATPase activity by the percent solubilized beta  subunit protein to give the values reported in the last column of Table IV. Support for using these calculations to determine the level of F1-F0 in the yeast diploids comes from the fact that nonassembled F1 is not extracted with Triton X-100 (19) and that under identical extraction conditions, the percentage of assembled F1-F0 that is solubilized should be the same in each of the samples. The reference value for F1-F0 catalytic activity is that measured with the double wild type diploid, W303×D273. Interestingly, control amounts of F1-F0 ATPase activity were measured in W303 nabla G1×D273, which is a diploid strain that harbors a single gene for the beta  subunit (Table IV). This result suggests that expression of ATP2 from either one or two wild type loci provides the diploid cell with the similar complement of the F1-F0 ATP synthase.

Table IV.

ATPase activity of diploid yeast that synthesize mutant forms of the F1 beta  subunit


Strain (mutation) Amount beta  subunit (soluble)a ATPase activity
 -Oligomycinb +Oligomycinb Oligomycin-sensitive activity
Mitochondrial F1-F0c

% control level µmol Pi/min/mg µmol Pi/min/mgd % control level
W303×D273 100 3.60 (3.40) 0.75 (0.90) 2.67 100
W303nabla G1×D273 (null) 83 2.60 (2.50) 0.40 (0.50) 2.10 94.4
W303×P159 (A192V) 80 2.10 (2.20) 0.20 (0.15) 1.97 92.1
W303×E430 (E222K) 88 1.20 (1.00) 0.50 (0.24) 0.73 30.9
W303×E588 (R293K) 81 1.80 (1.95) 0.25 (0.30) 1.60 73.7
W303×P133 (G133D) 65 1.50 (1.50) 0.40 (0.20) 1.20 68.9
W303×E210 (P179L) 89 2.80 (2.50) 0.60 (0.27) 2.21 92.9
W303×N123 (G227D) 85 2.50 (2.60) 0.23 (0.32) 2.27 99.9

a  The amount of soluble F1 beta  subunit protein was determined using an AMBIS 4000 imaging system to scan Western blots of Triton X-100 mitochondrial extracts. The mean values from the analysis of two separate Western blots are reported; one of the blots used is shown in Fig. 5.
b  Results from the assay of two separate mitochondrial preparations are shown; one set of values is given in parentheses.
c  Values were calculated by dividing the mean percent mitochondrial ATPase activity by the mean percent F1 beta  subunit protein solubilized with Triton X-100.
d  The mean values are reported.


Fig. 5. Western analysis of Triton X-100 extracts from mitochondria of yeast diploid strains. Mitochondria, prepared from the yeast diploids shown, were extracted with 0.25% Triton X-100 and centrifuged as described under ``Experimental Procedures.'' Equal volumes of each supernatant were analyzed by Western analysis to detect the F1 alpha  and beta  subunits as described in the legend to Fig. 1. The volume of the supernatant loaded onto the protein gel was equivalent to 20 µg of the starting mitochondrial protein.
[View Larger Version of this Image (40K GIF file)]


Assuming that random interactions occur among the F1 subunits from both parental cells, there is the potential to form four types of enzyme oligomers in the wild type/mutant diploids: a 3beta wt, a 3beta mut, and two types of hybrids (2beta wt1beta mut and 1beta wt2beta mut). All four enzyme types are expected to form in diploids if the resident mutant beta  subunit does not affect F1 assembly. With respect to the strains shown in Table IV, this situation applies to W303×P159, W303×E430, and W303×E588. In such strains, the 3beta wt and 3beta mut enzymes are each expected to comprise 12.5% of the total F1 oligomer population; the hybrid forms constitute, cumulatively, the remaining 75% of enzyme (35). Since the P159, E430, and E588 haploid strains are devoid of ATPase activity (Table III), it is assumed that the 3beta mut F1 formed in the derivative diploid cells is inactive. In cases where the 3beta mut F1 is the only inactive form of the enzyme, the maximal level of ATPase activity expected for the diploid strain is 87.5% (cumulative activity from the 3beta wt and hybrid enzymes). This value is within 5% error of the ATPase activity observed for W303×P159 (Table IV). Therefore, it would appear that this particular diploid forms fully active F1 hybrids in addition to the 3beta wt enzyme. The other two members of this diploid class exhibit 31 and 74% the control level of F1-F0 ATPase activity. Both values are in between the maximum (87.5%) and minimum (12.5%) levels of enzyme activity expected in this analysis, which suggests the presence of partially active F1 hybrids in addition to the fully wild type enzyme. The reduction in the activity of the hybrid enzymes is most striking for W303×E430, suggesting that the E222K mutation displays significant dominance over the wild type ATP2 allele present in the diploid cell.

The other three wild type/mutant diploid strains shown in Table IV (W303×P133, W303×E210, W303×N123) synthesize mutant beta  subunits that do not assemble into an F1 structure in the respective haploid strains (Figs. 2 and 4). Therefore, it is assumed that the 3beta mut enzyme does not form in these particular diploids. It is also likely that mutations, which affect the ability of the beta  subunit to assemble homogeneous mutant enzymes, will also prevent the formation of hybrid structures. In such cases the presence of the mutant atp2 gene would be no worse than having the null allele, since the pool of wild type subunits would not be used to form F1 hybrids. As only the 3beta wt enzyme would be synthesized in the diploid cell, one should see levels of F1-F0 ATPase activity comparable with that of the W303nabla G1×D273 strain (Table IV). This result is observed with W303×E210 and W303×N123 (Table IV), suggesting that the mutant beta  subunits synthesized in these strains do not interact with wild type F1 subunits. In contrast, the diploid strain W303×P133 shows 69% the control level of F1-F0 ATPase activity. The submaximal level of enzyme activity observed indicates that this diploid harbors hybrid forms of F1 and that these enzymes are only partially active.

It is likely that the partial dominance of the E222K, R293K, and G133D mutations was not recognized from simple complementation assays, because the respective diploid strains display >= 30% the control level of the enzyme activity. It has been reported that yeast mutants, with as little as 15% the wild type level of mitochondrial ATPase activity, are competent for growth on nonfermentable carbon sources (36).


DISCUSSION

With the exception of the initiator methionine change to isoleucine, the atp2 mutations reported in this paper are located in the central alpha beta domain of the protein. This portion of the beta  subunit encompasses the adenine nucleotide binding site and contains the P-loop region, which is a sequence element found in many nucleotide-binding proteins, including adenylate kinase and p21ras (37). Fig. 6 shows the alignment for part of the alpha beta domains of the S. cerevisiae and E. coli F1 beta  subunits. The amino acids of the bovine alpha beta domain, which participate directly in ATP binding, are known from the x-ray structure of bovine F1 (6); these residues are identically conserved in the yeast and bacterial sequences and are indicated in Fig. 6 with arrows. The yeast amino acids that are altered by the atp2 mutations described are boxed in the yeast sequence. The black boxes denote amino acids (Gly133, Pro179, and Gly227) where the mutation alters enzyme assembly. The open boxes indicate amino acids (Ala192, Glu222, and Arg293) where the mutations affect the catalytic activity of the enzyme, while leaving the F1-F0 structure intact. Notably, these latter three yeast amino acids align with residues in the E. coli sequence (circled amino acids, Fig. 6) that have been analyzed in mutagenesis studies. The complementary information derived from the current work and from studies with the bacterial enzyme is outlined below.


Fig. 6. Sequence alignment for part of the adenine nucleotide binding domain of the E. coli and S. cerevisiae F1 beta  subunit. Numbering of the E. coli sequence is according to Refs. 3 and 4. The yeast sequence starts with the initiator methionine as amino acid 1. Arrows indicate the amino acids homologous to the bovine residues that were shown to participate directly in binding adenine nucleotides (6). The boxed amino acids in the yeast sequence, and the circled residues in the bacterial sequence are discussed in detail in the text. The highly conserved P-loop region is indicated by the bar in the figure.
[View Larger Version of this Image (27K GIF file)]


A192V

Chemical mutagenesis induced a change of the P-loop alanine to valine both in yeast (Table II) and in E. coli (38). The phenotype described for the bacterial A151V mutant (38) is similar to what we have determined for the yeast strain, P159; the F1-F0 assembles correctly, yet is deficient in membrane-bound ATPase activity (Table III, Fig. 3). Our results are also in accord with Shen et al. (15) who screened mutations in the yeast beta  subunit P-loop region and found that mutants with the A192V change were respiratory-deficient. The position occupied by alanine in the P-loop of the F1 beta  subunit is a glycine residue in p21ras; notably, a mutant Ras protein with diminished GTPase activity was isolated in which this glycine residue is changed to valine (39). Apparently, substitution of valine at the 3rd position of the conserved P-loop (GXXXXGKT/S) has a global effect on the catalytic activity of NTP hydrolyzing enzymes that contain this consensus sequence. In E. coli F1, the A151V mutation produces a dramatic decrease in promotion from unisite to multisite catalysis (38). Our results with the W303×P159 diploid (Table IV) indicate that hybrid forms of F1, which contain either one or two beta  subunits with the corresponding A192V mutation, are fully active. Therefore, it would appear that the P-loop Ala right-arrow Val mutation only blocks F1 catalysis in enzyme oligomers homogenous for the mutant subunit.

E222K

The phenotype of yeast harboring the chemically induced E222K mutation (strains E430 and E144, Table II) can be compared with the E. coli E181Q beta  subunit mutant derived from site-specific mutagenesis (40). Mutation of this glutamate residue to either lysine or glutamine does not interfere with F1-F0 assembly, but lowers the steady-state level of membrane-bound ATPase activity to 2% the wild type level in haploid strains (Fig. 3, Table III (40, 41). The fact that mutagenesis studies in yeast (present work) and in bacteria (41) give importance to this glutamate residue in the F1 catalytic mechanism is in accord with structural information obtained with the bovine enzyme (6). The equivalent glutamate residue in the bovine beta  subunit (Glu188) contributes to ATP binding in the catalytic site, and there is electron density in the map that could represent a water molecule hydrogen bonded to its carboxylate group (6). These observations have led the authors to suggest that Glu188 activates the water, promoting an in-line nucleophilic attack on the gamma -phosphate of ATP during F1 turnover (6). The dramatic effect on F1 catalytic activity that occurs when this glutamate residue is mutated is also readily apparent in diploid yeast (Table IV) and in E. coli transformants (41, 42) that synthesize hybrid forms of the enzyme. Our results with the W303×E430 strain (Table IV) suggest that F1 catalysis is severely inhibited in F1 hybrids containing the mutant subunit, which supports the idea that the affected glutamate residue is important for cooperative interactions in the enzyme.

R293K

The yeast R293K beta  subunit mutation produces a near complete loss of ATP hydrolytic activity in the haploid strain E588 (Table III). Two different mutations of the corresponding arginine residue in the E. coli beta  subunit (R246C (43) and R246H (34)) were obtained by chemical mutagenesis. The phenotypes of both bacterial mutants are similar and correlate well with the defect of the corresponding yeast mutant. The catalytic impairment observed when this arginine residue is mutated is not unexpected, since the equivalent amino acid in the bovine beta  subunit (Arg260) participates in binding the triphosphate moiety of ATP in the catalytic site (6). In the diploid that harbors one copy of the mutant allele (Table IV), the mutation R293K reduces the maximum steady-state level of ATPase activity by 17%. This result implies that there is only a modest effect on catalytic cooperativity in hybrid enzymes that contain this particular mutant beta  subunit.

The other three beta  subunit mutations (G133D, P179L, and G227D) reported in the present work are novel in that they alter amino acids different from those studied previously in yeast or bacteria. The overall phenotype of the haploid mutants (P133, E210, and N123) is defective F1 assembly with the accumulation of the alpha  and beta  subunits in large aggregates inside mitochondria (Fig. 4). However, analysis of the wild type/mutant diploid strains (Table IV) indicates two subphenotypes, distinguished on the basis of whether or not the mutant beta  subunit can interact with other F1 subunits. The beta  subunits from E210 and N123 do not form hybrid F1 enzymes in the derivative diploid strains, while the P133 beta  subunit does. The position of the mutated residues was identified in the structure of the bovine mitochondrial F1 (coordinates were kindly provided by A. Leslie and J. E. Walker, Medical Research Council, Cambridge, United Kingdom (UK)). In E210, the mutation alters Pro179; in the bovine protein this residue (Pro145) is located at the interface with one of the alpha  subunits, in close proximity to the nonexchangeable adenine nucleotide binding site (6). The mutation of N123 alters residue Gly227; the corresponding glycine (Gly193) in the bovine beta  subunit is in close juxtaposition with the other adjacent alpha  subunit. The fact that the E210 and N123 mutations alter beta  subunit amino acids that interact with neighboring F1 subunits supports the notion that the mutated proteins do not assemble hybrid enzymes in diploid cells. The P133 mutation produces a change in Gly133; in the bovine beta , the equivalent residue (Gly99) is located at the junction between the amino-terminal beta  barrel and central alpha beta tertiary structural domains in the beta  subunit (6). This glycine residue is structurally distant from adjacent F1 subunits, which may explain why a mutation of this amino acid does not preclude the mutant subunit from interacting with the other enzyme subunits. However, inspection of the x-ray structure of bovine F1 shows that the G133D mutation of strain P133 is likely to disturb the three-dimensional structure of the beta  subunit, since the space in the vicinity of the glycine residue is too small to accommodate the mutation to aspartic acid. The presumed structural perturbation might be responsible for the reduced level of F1-F0 specific activity and for the smaller amount of soluble beta  subunit detected in W303×P133 with respect to the other diploid strains (Table IV). Thus, in addition to assembling catalytically impaired hybrid enzymes, the P133 mutant beta  subunit probably engages in nonproductive interactions that lower the steady-state level of assembled (soluble) F1-F0.

The type of F1 assembly defect observed in the atp2 mutants described here is also seen in yeast mutants where the genetic lesion affects the Atp11p and Atp12p F1 assembly factor proteins (19). The proposed function of the F1-specific ``chaperone-type'' proteins (Atp11p and Atp12p) is to ensure that productive associations between F1 alpha  and beta  subunits prevail over the formation of nonproductive alpha n and beta n complexes (44). In light of evidence for direct binding between Atp11p and the F1 beta  subunit (45), the atp2 mutations that correlate with an F1 aggregation+ phenotype are of particular interest, since they may affect amino acids that interact with the assembly factor.


FOOTNOTES

*   This research was supported by National Institutes of Health Grant GM48157. The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked ``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) U46215[GenBank].


Dagger    To whom correspondence and requests for reprints should be addressed. Tel.: 313-577-8645; Fax: 313-577-7642; E-mail: sackerm{at}cms.cc.wayne.edu.
1   The biochemical characteristics are described for the mutants E210 and E430 as the strains representative of the P179L and E222K mutations, respectively.

Acknowledgments

We are grateful to Andrew Leslie and John Walker at the Medical Research Council in Cambridge, UK for providing us with the coordinates of the bovine F1 structure. We also thank Domenico Gatti and Alexander Tzagoloff for their critical evaluation of the manuscript.


REFERENCES

  1. Penefsky, H. S., Cross, R. L. (1991) Adv. Enzymol. 64, 173-214
  2. Boyer, P. D. (1993) Biochim. Biophys. Acta 1140, 215-250 [Medline] [Order article via Infotrieve]
  3. Futai, M., Kanazawa, H. (1983) Microbiol. Rev. 47, 285-312 [Free Full Text]
  4. Walker, J. E., Saraste, M., Gay, N. J. (1984) Biochim. Biophys. Acta 768, 164-200 [Medline] [Order article via Infotrieve]
  5. Collinson, I. R., Runswick, M. J., Buchanan, S. K., Fearnley, I. M., Skehel, J. M., vaan Raaij, M. J., Griffiths, D. E., Walker, J. E. (1994) Biochemistry 33, 7971-7978 [CrossRef][Medline] [Order article via Infotrieve]
  6. Abrahams, J. P., Leslie, A. G. W., Lutter, R., Walker, J. E. (1994) Nature 370, 621-628 [CrossRef][Medline] [Order article via Infotrieve]
  7. Futai, M., Noumi, T., Maeda, M. (1988) J. Bioenerg. Biomembr. 20, 41-58 [CrossRef][Medline] [Order article via Infotrieve]
  8. Futai, M., Noumi, T., Maeda, M. (1989) Annu. Rev. Biochem. 58, 111-136 [CrossRef][Medline] [Order article via Infotrieve]
  9. Senior, A. E. (1990) Annu. Rev. Biophys. 19, 7-41
  10. Takeda, M., Vassarotti, A., Douglas, M. G. (1985) J. Biol. Chem. 260, 15458-15465 [Abstract/Free Full Text]
  11. Takeda, M., Okushiba, T., Hayashida, T., Gunge, N. (1994) Yeast 10, 1531-1534 [CrossRef][Medline] [Order article via Infotrieve]
  12. Mueller, D. M. (1988) J. Biol. Chem. 263, 5634-5639 [Abstract/Free Full Text]
  13. Mueller, D. M. (1989) Biochem. Biophys. Res. Commun. 164, 381-386 [CrossRef][Medline] [Order article via Infotrieve]
  14. Mueller, D. M. (1989) J. Biol. Chem. 264, 16552-16556 [Abstract/Free Full Text]
  15. Shen, H., Yao, B., Mueller, D. M. (1994) J. Biol. Chem. 269, 9424-9428 [Abstract/Free Full Text]
  16. Tzagoloff, A., Akai, Foury, F. (1976) FEBS Lett. 65, 291-395
  17. Tzagoloff, A., Dieckmann, C. L. (1990) Microbiol. Rev. 54, 211-225 [Abstract/Free Full Text]
  18. Faye, G., Kujawa, C., Fukuhara, H. (1974) J. Mol. Biol. 88, 185-203 [CrossRef][Medline] [Order article via Infotrieve]
  19. Ackerman, S. H., Tzagoloff, A. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 4986-4990 [Abstract/Free Full Text]
  20. Grunstein, M., Hogness, D. S. (1975) Proc. Natl. Acad. Sci. U. S. A. 72, 101-106
  21. Sikorski, R. S., Hieter, P. (1989) Genetics 122, 19-27 [Abstract/Free Full Text]
  22. Hill, J. E., Myers, A. M., Koerner, T. J., Tzagoloff, A. (1986) Yeast 2, 163-167 [CrossRef][Medline] [Order article via Infotrieve]
  23. Rothstein, R. J. (1983) Methods Enzymol. 101, 202-211 [Medline] [Order article via Infotrieve]
  24. Lowry, O. H., Rosebrough, N. J., Farr, A. L., Randall, R. J. (1951) J. Biol. Chem. 193, 265-275 [Free Full Text]
  25. Ackerman, S. H., Tzagoloff, A. (1990) J. Biol. Chem. 265, 9952-9959 [Abstract/Free Full Text]
  26. Maniatis, T., Fritsch, E. F., Sambrook, J. (1982) Molecular Cloning: A Laboratory Manual , Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
  27. Sanger, F., Nicklen, S., Coulson, A. R. (1977) Proc. Natl. Acad. Sci. U. S. A. 74, 5463-5467 [Abstract/Free Full Text]
  28. Schiestl, R. H., Gietz, R. D. (1989) Curr. Genet. 16, 339-346 [CrossRef][Medline] [Order article via Infotrieve]
  29. Laemmli, U. K. (1970) Nature 227, 680-685 [CrossRef][Medline] [Order article via Infotrieve]
  30. Schmidt, R. J., Myers, A. M., Gillham, N. W., Boynton, F. E. (1984) Mol. Biol. Evol. 1, 317-334 [Abstract]
  31. Bullough, D. A., Allison, W. S. (1986) J. Biol. Chem. 261, 14171-14177 [Abstract/Free Full Text]
  32. Ackerman, S. H., Grubmeyer, C., Coleman, P. S. (1987) J. Biol. Chem. 262, 13765-13772 [Abstract/Free Full Text]
  33. Rao, R., Senior, A. E. (1987) J. Biol. Chem. 262, 17450-17454 [Abstract/Free Full Text]
  34. Noumi, T., Taniai, M., Kanazawa, H., Futai, M. (1986) J. Biol. Chem. 261, 9196-9201 [Abstract/Free Full Text]
  35. Walpole, R. E., Myers, R. H. (1978) Probability and Statistics for Engineers and Scientists , 2nd Ed. , p. 12, Macmillan Publishing Co., Inc., New York
  36. Mukhopadhyay, A., Uh, M., Mueller, D. M. (1994) FEBS Lett. 343, 160-164 [CrossRef][Medline] [Order article via Infotrieve]
  37. Walker, J. E., Fearnley, I. M., Gay, N. J., Gibson, B. W., Northrop, F. D., Powell, S. J., Runswick, M. J., Saraste, M., Tybulewicz, V. L. J. (1985) J. Mol Biol. 184, 677-701 [CrossRef][Medline] [Order article via Infotrieve]
  38. Hsu, S.-Y., Noumi, T., Takeyama, M., Maeda, M., Ishibashi, S., Futai, M. (1987) FEBS Lett. 218, 222-226 [CrossRef][Medline] [Order article via Infotrieve]
  39. Reddy, E. P., Reynolds, R. K., Santos, E., Barbacid, M. (1982) Nature 300, 149-152 [CrossRef][Medline] [Order article via Infotrieve]
  40. Parsonage, D., Wilke-Mounts, S., Senior, A. E. (1988) Arch. Biochem. Biophys. 261, 222-225 [CrossRef][Medline] [Order article via Infotrieve]
  41. Senior, A. E., Al-Shawi, M. K. (1992) J. Biol. Chem. 267, 21471-21478 [Abstract/Free Full Text]
  42. Al-Shawi, M. K., Parsonage, D., Senior, A. E. (1989) J. Biol. Chem. 264, 15376-15383 [Abstract/Free Full Text]
  43. Parsonage, D., Duncan, T. M., Wilke-Mounts, S., Kironde, F. A. S., Hatch, L., Senior, A. E. (1987) J. Biol. Chem. 262, 6301-6307 [Abstract/Free Full Text]
  44. Wang, Z.-G., Ackerman, S. H. (1996) J. Biol. Chem. 271, 4887-4894 [Abstract/Free Full Text]
  45. Ackerman, S. H., Martin, J., Tzagoloff, A. (1992) J. Biol. Chem. 267, 7386-7394 [Abstract/Free Full Text]

©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Eukaryot CellHome page
C. P. Smith and P. E. Thorsness
Formation of an Energized Inner Membrane in Mitochondria with a {gamma}-Deficient F1-ATPase
Eukaryot. Cell, December 1, 2005; 4(12): 2078 - 2086.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Schwimmer, L. Lefebvre-Legendre, M. Rak, A. Devin, P. P. Slonimski, J.-P. di Rago, and M. Rigoulet
Increasing Mitochondrial Substrate-level Phosphorylation Can Rescue Respiratory Growth of an ATP Synthase-deficient Yeast
J. Biol. Chem., September 2, 2005; 280(35): 30751 - 30759.
[Abstract] [Full Text] [PDF]


Home page
GeneticsHome page
C.-Y. Lai, E. Jaruga, C. Borghouts, and S. M. Jazwinski
A Mutation in the ATP2 Gene Abrogates the Age Asymmetry Between Mother and Daughter Cells of the Yeast Saccharomyces cerevisiae
Genetics, September 1, 2002; 162(1): 73 - 87.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available